A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma-Reference-Cited by-同舟云学术

A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma

Published:2023-10-25 Issue: Volume: Page:
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Tang Shi-Chuan,Zhang Kai-Ling,Lin Kong-Ying,Tang Yi-Dan,Fu Jun,Zhou Wei-Ping,Zhang Jian-Xi,Kong Jie,He Xiao-Lu,Sun Zheng-Hong,Luo Cong,Liu Hong-Zhi,Lai Yong-Ping^ORCID,Zeng Yong-Yi

Funder

The National Natural Science Foundation of China

The Scientific Foundation of Fuzhou Municipal Health commission

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-023-10602-0.pdf

Reference48 articles.

1. Brown ZJ, Tsilimigras DI, Ruff SM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158(4):410–420. https://doi.org/10.1001/jamasurg.2022.7989

2. Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. https://doi.org/10.1016/j.jhep.2021.11.018

3. Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362. https://doi.org/10.1016/S0140-6736(22)01200-4

4. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. https://doi.org/10.1002/hep.29086

5. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234(1):71–78. https://doi.org/10.1097/00000658-200107000-00011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on ‘Effect of anatomical liver resection for hepatocellular carcinoma a systematic review and meta-analysis’;International Journal of Surgery;2024-02-13

2. miR-557 suppresses hepatocellular carcinoma cell proliferation and migration via downregulating CBX4;BIOCELL;2024